Researchers from the Belgian universities of Brussels and Ghent claim to have developed an mRNA-based vaccine that can boost the immune system in the event of the presence of the human immunodeficiency virus – HIV, the portal “Focus on Belgium” reported.

According to the scientists, the aim of this vaccine developed in Belgium would be to control HIV. The drug, in fact, uses lipid nanoparticles that “contain an additional stimulating signal for the immune system”, which increases the effectiveness of the vaccine, as one of the researchers said.

They also say the vaccine could drastically reduce dependence on existing daily medications.

If its benefits are proven in humans (it has only been tested on laboratory mice so far), this new vaccine could bring significant help and hope to people living with HIV.